- Home
- ALDX vs MAPS Comparison
ALDX vs MAPS Comparison
Compare ALDX & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- MAPS
- Stock Information
- Founded
- ALDX 2004
- MAPS 2008
- Country
- ALDX United States
- MAPS United States
- Employees
- ALDX N/A
- MAPS N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- MAPS Computer Software: Prepackaged Software
- Sector
- ALDX Health Care
- MAPS Technology
- Exchange
- ALDX Nasdaq
- MAPS Nasdaq
- Market Cap
- ALDX 133.7M
- MAPS 131.9M
- IPO Year
- ALDX 2014
- MAPS N/A
- Fundamental
- Price
- ALDX $2.24
- MAPS $1.11
- Analyst Decision
- ALDX Strong Buy
- MAPS Strong Buy
- Analyst Count
- ALDX 2
- MAPS 1
- Target Price
- ALDX $9.50
- MAPS $2.61
- AVG Volume (30 Days)
- ALDX 1.5M
- MAPS 612.1K
- Earning Date
- ALDX 05-20-2025
- MAPS 05-08-2025
- Dividend Yield
- ALDX N/A
- MAPS N/A
- EPS Growth
- ALDX N/A
- MAPS N/A
- EPS
- ALDX N/A
- MAPS 0.08
- Revenue
- ALDX N/A
- MAPS $184,514,000.00
- Revenue This Year
- ALDX N/A
- MAPS $0.86
- Revenue Next Year
- ALDX N/A
- MAPS $12.85
- P/E Ratio
- ALDX N/A
- MAPS $14.24
- Revenue Growth
- ALDX N/A
- MAPS N/A
- 52 Week Low
- ALDX $1.14
- MAPS $0.70
- 52 Week High
- ALDX $7.20
- MAPS $1.65
- Technical
- Relative Strength Index (RSI)
- ALDX 36.53
- MAPS 47.58
- Support Level
- ALDX $1.90
- MAPS $1.11
- Resistance Level
- ALDX $2.89
- MAPS $1.21
- Average True Range (ATR)
- ALDX 0.22
- MAPS 0.07
- MACD
- ALDX 0.09
- MAPS 0.00
- Stochastic Oscillator
- ALDX 33.46
- MAPS 39.29
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.